DiaMedica Board of Directors, Key People and Executives

Health Care & Life Sciences » Biotechnology | DiaMedica Inc.

DiaMedica Inc. | Key People and Executives

Rick John Pauls

President, Chief Executive Officer & Director

Richard D. Pilnik

Chairman

Zhen Yu Xiao

Independent Director

James T. Parsons

Independent Director

Michael R. Giuffre

Independent Director

Rick John Pauls

President, Chief Executive Officer & Director

Scott Kellen

Chief Financial Officer & Secretary

Harry Alcorn

Chief Medical Officer

Todd A. Verdoorn

Chief Scientific Officer

Paul Papi

Vice President-Business Development

Richard Dal Pilnik

Chairman

Zhen Yu Xiao

Independent Director

James T. Parsons

Independent Director

Michael R. Giuffre

Independent Director

View Profile

Address	2 Carlson Parkway North Minneapolis Minnesota 55447 United States
Employees	-
Website	http://www.diamedica.com
Updated	09/14/2018
DiaMedica Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the development of novel recombinant proteins. Its products includes DM199 that focused on acute ischemic stroke, and chronic kidney disease; and KLK1 which plays a critical role in the regulation of local blood flow, vasodilation in the body, inflammation, and oxidative stress. The company was founded by Wayne Lautt on January 21, 2000 and is headquartered in Minneapolis, MN.